Kura Oncology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $647.2M
Liabilities Breakdown FY2020
Total Liabilities: $36.3M
Asset Breakdown
Total Assets: $647.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $325.5M | 50.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.0M | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $319.7M | 49.4% |
Liabilities Breakdown
Total Liabilities: $36.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.8M | 7.6% |
| Long-Term Debt | $4.3M | 11.7% |
| Other Liabilities | $29.3M | 80.7% |